These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16166852)

  • 1. A rare case of paraneoplastic cerebellar degeneration discovered by whole-body F-18 FDG PET.
    Rubello D; Vitaliani R; Rigoni MT; Rampin L; Giometto B; Casara D; Zonzin GC; Zavagno G; Capirci C; Shapiro B; Muzzio PC
    Clin Nucl Med; 2005 Oct; 30(10):704-6. PubMed ID: 16166852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.
    Marchand V; Graveleau J; Lanctin-Garcia C; Bourbouloux E; Bridji B; Resche I; Kraeber-Bodéré F; Rousseau C
    Gynecol Oncol; 2007 May; 105(2):545-7. PubMed ID: 17368524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
    Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
    BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical insights into paraneoplastic cerebellar degeneration.
    Scheid R; Voltz R; Briest S; Kluge R; von Cramon DY
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):529-30. PubMed ID: 16543537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of slowly progressive anti-Yo-associated paraneoplastic cerebellar degeneration successfully treated with antitumor and immunotherapy].
    Tsuboguchi S; Yajima R; Higuchi Y; Ishikawa M; Kawachi I; Koyama Y; Nishizawa M
    Rinsho Shinkeigaku; 2016 Jul; 56(7):477-80. PubMed ID: 27356731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gross cerebellar paraneoplastic neurological disorder in a patient with an occult breast cancer.
    Poudel CK; Achar KN
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23595173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar Degeneration.
    Thapa P; Basu S
    J Nucl Med Technol; 2016 Mar; 44(1):52-3. PubMed ID: 26271804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X; Wu F; Han P
    Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
    Liu S; Tunkel R; Lachmann E; Nagler W
    Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
    Kawata S; Imaizumi M; Kako Y; Oku N
    Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Yo mediated paraneoplastic cerebellar degeneration in the context of breast cancer: a case report and literature review.
    Key RG; Root JC
    Psychooncology; 2013 Sep; 22(9):2152-5. PubMed ID: 23585287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast.
    Kumar R; Xiu Y; Dhurairaj T; Yu JQ; Alavi A; Zhuang H
    Clin Nucl Med; 2005 Apr; 30(4):246-8. PubMed ID: 15764881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer revealed by a paraneoplastic cerebellar syndrome: about one case and literature review.
    Adama D; Moussa B; Emmanuel M; Dennis U
    Pan Afr Med J; 2015; 22():25. PubMed ID: 26664526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
    Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
    Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
    Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
    Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.